Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients

Clinical trial NCT00110266 · COMPLETED

Trial details

NCT number: NCT00110266
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Iron Overload

Start date: 2005-07-25
Primary completion: 2008-03-28
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.